LEONARDO DRS, INC. (DRS)

Director Baylouny John 🟡 adjusted position in 25.9K shares (3 derivative) of Leonardo DRS, Inc. (DRS) at $45.86 ($1.9M) Transaction Date: Apr 01, 2026 | Filing ID: 000002

Register to leave comments

  • News bot April 3, 2026, 9:07 p.m.

    🔍 Baylouny John (Director)

    Company: Leonardo DRS, Inc. (DRS)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 13
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 94,915
    • Total shares sold: 68,976

    Detailed Transactions and Holdings:

    • Acquired 40,681 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 146,688.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 17,555 shares of Common Stock at $45.86 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 129,133.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 27,274 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 156,407.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 12,301 shares of Common Stock at $45.85 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 144,106.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 12,627 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 156,733.00 | transaction_form_type: 4
    • Sold 5,695 shares of Common Stock at $45.86 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 151,038.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 8,325 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 159,363.00 | transaction_form_type: 4
    • Sold 3,755 shares of Common Stock at $45.86 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 155,608.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 6,008 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 161,616.00 | transaction_form_type: 4
    • Sold 2,710 shares of Common Stock at $45.86 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 158,906.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 12,627 shares of Restricted Stock Unit (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F4, F4
    • Sold 8,325 shares of Restricted Stock Unit (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,327.00 | transaction_form_type: 4 | Footnotes: F5, F5, F5
    • Sold 6,008 shares of Restricted Stock Unit (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,018.00 | transaction_form_type: 4 | Footnotes: F6, F6, F6

    Footnotes:

    • F1: Represents performance restricted stock units ("PRSUs") awarded in April 2023 under the Issuer's 2022 Omnibus Equity Compensation Plan (the "Plan") for the performance period January 1, 2023 through December 31, 2025, for which performance goals have been achieved and certified on February 19, 2026. Each PRSU represents the right to one share of the Issuer's common stock. The PRSUs vested on April 1, 2026.
    • F2: Shares withheld by the Issuer to satisfy tax withholding requirements.
    • F3: Represents PRSUs awarded in April 2023 under the Plan for the performance period January 1, 2023 through December 31, 2025, for which performance goals have been achieved and certified on February 19, 2026. Each PRSU represents the right to one share of the Issuer's common stock. The PRSUs vested on April 1, 2026.
    • F4: Each restricted stock unit ("RSU") was granted under the Plan, and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. One-third of the RSUs vested on each of April 1, 2024 and April 1, 2025. The remaining RSUs vested one-third on April 1, 2026.
    • F5: Each RSU was granted under the Plan and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. One-third of the RSUs vested on each of April 1, 2025 and April 1, 2026. The remaining one-third of RSUs are scheduled to vest on April 1, 2027, subject to the Reporting Person's continued employment with the Issuer through such date. The number of RSUs that vest on each of April 1, 2025 and April 1, 2026 shall be rounded down to the nearest whole number of RSUs and the remaining RSUs shall vest on April 1, 2027.
    • F6: Each RSU was granted under the Plan, and represents a contingent right to receive one share of the common stock of the Issuer or the cash equivalent thereof. One-third of the RSUs vested on April 1, 2026. The remaining RSUs are scheduled to vest one-third annually on each of April 1, 2027 and April 1, 2028, subject to the Reporting Person's continued employment with the Issuer through each date. The number of RSUs that vest on each of April 1, 2026 and April 1, 2027 shall be rounded down to the nearest whole number of RSUs and the remaining RSUs shall vest on April 1, 2028.
    • REMARKS: Exhibit 24.1 - Power of Attorney